All Stories

  1. Metabolism of Direct-Acting Antiviral Agents (DAAs) in Hepatitis C Therapy: A Systematic Review

    Article • Current Drug Metabolism, December 2020, Bentham Science Publishers

    Dr Ivana Mikolasevic, Petra Puz, Lucija Virović Jukić, Toni Juric

  2. Dyslipidemia in patients with chronic kidney disease: etiology and management

    Article • International Journal of Nephrology and Renovascular Disease, February 2017, Dove Medical Press

    Dr Ivana Mikolasevic

  3. Nonalcoholic Fatty Liver Disease (NAFLD)—A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients

    Article • Peritoneal Dialysis International, July 2016, SAGE Publications

    Dr Ivana Mikolasevic

  4. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options

    Article • Drug Design Development and Therapy, August 2015, Dove Medical Press

    Dr Ivana Mikolasevic

  5. Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients

    Article • Clinical Interventions in Aging, August 2014, Dove Medical Press

    Dr Ivana Mikolasevic, Branka Sladoje-Martinović

  6. Survival of chronic hemodialysis patients over 80 years of age

    Article • Clinical Interventions in Aging, April 2014, Taylor & Francis

    Dr Ivana Mikolasevic, Branka Sladoje-Martinović